| Natriuretic peptide–based screening and collaborative care for heart failure: the STOP-HF randomized trial M Ledwidge, J Gallagher, C Conlon, E Tallon, E O’Connell, I Dawkins, ... Jama 310 (1), 66-74, 2013 | 634 | 2013 |
| Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? P Collier, CJ Watson, V Voon, D Phelan, A Jan, G Mak, R Martos, ... European journal of heart failure 13 (10), 1087-1095, 2011 | 252 | 2011 |
| Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease … N Glezeva, V Voon, C Watson, S Horgan, K McDonald, M Ledwidge, ... Journal of cardiac failure 21 (2), 167-177, 2015 | 145 | 2015 |
| Cost‐effectiveness of natriuretic peptide‐based screening and collaborative care: a report from the STOP‐HF (St Vincent's Screening TO Prevent Heart Failure) study MT Ledwidge, E O'Connell, J Gallagher, L Tilson, S James, V Voon, ... European journal of heart failure 17 (7), 672-679, 2015 | 51 | 2015 |
| Can individualized weight monitoring using the HeartPhone algorithm improve sensitivity for clinical deterioration of heart failure? MT Ledwidge, R O'Hanlon, L Lalor, B Travers, N Edwards, D Kelly, ... European journal of heart failure 15 (4), 447-455, 2013 | 42 | 2013 |
| Life expectancy for community-based patients with heart failure from time of diagnosis S James, D Barton, E O'Connell, V Voon, G Murtagh, C Watson, T Murphy, ... International journal of cardiology 178, 268-274, 2015 | 32 | 2015 |
| Attenuation of monocyte chemotaxis—a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide N Glezeva, P Collier, V Voon, M Ledwidge, K McDonald, C Watson, ... Journal of cardiovascular translational research 6, 545-557, 2013 | 30 | 2013 |
| Importance of risk factor management in diabetic patients and reduction in Stage B heart failure G Murtagh, J O Connell, E O Connell, E Tallon, C Watson, J Gallagher, ... QJM: An International Journal of Medicine 108 (4), 307-314, 2015 | 11 | 2015 |
| Evaluating the role of transthoracic echocardiography in hospitalised patients with COVID-19 infection A Babu, Z Meng, N Eden, D Lamb, J Nouza, R Bhatia, IC Ster, J Bennett, ... Open Heart 9 (1), e001854, 2022 | 8 | 2022 |
| Randomized study comparing incidence of radial artery occlusion post-percutaneous coronary intervention between two conventional compression devices using a novel air-inflation … V Voon, M AyyazUlHaq, C Cahill, K Mannix, C Ahern, T Hennessy, ... World journal of cardiology 9 (11), 807, 2017 | 6 | 2017 |
| Troponin and short-term mortality in hospitalised patients with COVID-19 infection: a retrospective study in an inner-city London hospital V Shyam-Sundar, DF Stein, M Spazzapan, A Sullivan, C Qin, V Voon BMJ open 12 (8), e061426, 2022 | 4 | 2022 |
| Multi-modality imaging in transthyretin amyloid cardiomyopathy BP Traynor, A Shamsi, V Voon World Journal of Cardiology 11 (11), 266, 2019 | 3 | 2019 |
| Eosinophilic granulomatosis with polyangiitis associated myocarditis: role of myocardial tissue characterization V Voon, IC Chikanza, MY Khanji European Heart Journal-Cardiovascular Imaging 21 (6), 703-703, 2020 | 1 | 2020 |
| 12 Observations by transoesophageal echocardiography post-watchman implantation in atrial fibrillation: a cause for concern? B Traynor, V Voon, A McInerney, H Hussein, D Foley, BF McAdam Heart 103 (Suppl 6), A8-A8, 2017 | 1 | 2017 |
| 6 Can we do better in improving end of life care and symptom control in end-stage heart failure? V Voon, S Chew, C Craig, D White, E Wong, C Cahill, B Meany, ... Heart, A4, 2017 | 1 | 2017 |
| Para-device leaks, residual septal defects and thrombus observed by transoesophageal echocardiography post-Watchman implantation for atrial fibrillation V Voon, B Traynor, H Hussein, D Foley, B McAdam EUROPEAN HEART JOURNAL 38, 1297-1298, 2017 | 1 | 2017 |
| Incidence of symptom-driven Coronary Angiographic procedures post-drug-eluting Balloon treatment of Coronary Artery drug-eluting stent in-stent Restenosis-does it matter? V Voon, D Gumani, C Craig, C Cahill, K Mustafa, T Hennessy, S Arnous, ... J Cardiol Cardiovasc Med 2, 35-41, 2017 | 1 | 2017 |
| Pericardial absence—is symptomatic partial defect an enigmatic cardiovascular risk? V Voon, F Masood, A Khattak, D McWeeney, B Gibney, D Murphy, ... QJM: An International Journal of Medicine 108 (9), 733-734, 2015 | 1 | 2015 |
| The impact of natriuretic peptide-based screening and collaborative care on healthcare costs: an analysis of the STOP-HF study M Ledwidge, E O'Connell, J Gallagher, L Tilson, V Voon, M Bermingham, ... IRISH JOURNAL OF MEDICAL SCIENCE 183, S424-S425, 2014 | 1 | 2014 |
| Leptospiral myocarditis—a rare assault on myocardium V Voon, L Saiva, B Prendiville, D Brennan, J Dodd, C McCreery International Journal of Cardiology 172 (1), e76-e78, 2014 | 1 | 2014 |
